U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase II; Board on Population Health and Public Health Practice; Board on Global Health; Institute of Medicine; Madhavan G, Sangha K, Phelps C, et al., editors. Ranking Vaccines: A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System. Washington (DC): National Academies Press (US); 2013 Oct 17.

Cover of Ranking Vaccines

Ranking Vaccines: A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System.

Show details

References

  • Arrow KJ. A difficulty in the concept of social welfare. Journal of Political Economy. 1950;58(4):328–346.
  • Arrow KJ. Social choice and individual values. 2nd. New York: John Wiley & Sons; 1963.
  • Bagnoli F, Baudner B, Mishra RP, Bartolini E, Fiaschi L, Mariotti P, Nardi-Dei V, Boucher P, Rappuoli R. Designing the next generation of vaccines for global public health. OMICS: A Journal of Integrative Biology. 2011;15(9):545–566. [PubMed: 21682594]
  • Barron FH, Barrett B. The efficacy of SMARTER—Simple multi-attribute rating technique extended to ranking. Acta Psychologica. 1996;93(1):23–36.
  • Batson A. The problems and promise of vaccine markets in developing countries. Health Affairs. 2005;24(3):690–693. [PubMed: 15886160]
  • Bishai DM, Champion C, Steele ME, Thompson L. Product development partnerships hit their stride: Lessons from developing a meningitis vaccine for Africa. Health Affairs. 2011;30(6):1058–1064. [PubMed: 21653957]
  • Bloom DE, Canning D, Weston M. The value of vaccination. World Economics. 2005;6(3):15–40.
  • Brilliant L, Foege W. Lessons from smallpox guide polio endgame. 2013. [May 31, 2013]. (Scientific American, April 22). http://blogs​.scientificamerican​.com/guest-blog​/2013/04/22/lessons-from-smallpox-guide-polio-endgame.
  • Drummond M, Chevat C, Lothgren M. Do we fully understand the economic value of vaccines. Vaccine. 2007;25(32):5945–5957. [PubMed: 17629362]
  • Edwards W, Barron FH. SMARTS and SMARTER: Improved simple methods for multiattribute utility measurement. Organizational Behavior and Human Decision Processes. 1994;60(3):306–325.
  • HHS (U.S. Department of Health and Human Services. The 2010 National Vaccine Plan, protecting the nation's health through immunization. 2010. [May 31, 2013]. http://www​.hhs.gov/nvpo​/vacc_plan/2010%20Plan​/nationalvaccineplan.pdf.
  • IOM (Institute of Medicine). New vaccine development: Establishing priorities. Volume I, diseases of importance in the United States. Washington, DC: National Academy Press; 1985. [PubMed: 25032464]
  • IOM. New vaccine development: Establishing priorities. Volume II, Diseases of importance in developing countries. Washington, DC: National Academy Press; 1986. [PubMed: 25032464]
  • IOM. Vaccines for the 21st century: A tool for decisionmaking. Washington, DC: National Academy Press; 2000. [PubMed: 25121214]
  • IOM. Ranking Vaccines: A prioritization framework: Phase I: Demonstration of concept and a software blueprint. Washington, DC: The National Academies Press; 2012. [PubMed: 24851289]
  • Keeney R, Raiffa H. Decisions with multiple objectives: Preferences and value tradeoffs. New York: John Wiley & Sons; 1976.
  • Milstien J, Candries B. Economics of vaccine development and implementation: Changes over the past 20 years. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Health, National Institute of Allergy and Infectious Diseases; 2002.
  • Rappuoli R, Alderem A. Nature. 7348. Vol. 473. 2011. A 2020 vision for vaccines against HIV, tuberculosis and malaria; pp. 463–469. [PubMed: 21614073]
  • Rappuoli R, Black S, Lambert PH. Lancet. 9788. Vol. 378. 2011. Vaccine discovery and translation of new vaccine technology; pp. 360–368. [PubMed: 21664687]
  • Tomori O. From smallpox eradication to the future of global health: Innovations, application and lessons for future eradication and control initiatives. Vaccine. 2011;29(Suppl. 4):D145–D148. [PubMed: 22185830]
Copyright 2013 by the National Academy of Sciences. All rights reserved.
Bookshelf ID: NBK206789
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (9.9M)

Related information

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...